Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00501423
Status:
COMPLETED
Last Update Posted:
2014-01-31
First Post:
2007-07-13
Brief Title:
Antiplatelet Drug Resistances and Ischemic Events
Sponsor:
Pierre Fontana
Organization:
University Hospital Geneva
Study Overview
Official Title:
Antiplatelet Drug Resistances and Ischemic Events
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ADRIE
Brief Summary:
The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients
Detailed Description:
The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients
Main objective
to determine if platelet reactivity assessed by specific and non-specific tests is predictive of ischemic events during the 3-year follow-up
Secondary objectives
primary outcome in each pre-specified sub-group patients with coronary artery disease ischemic stroke or peripheral arterial disease as main qualifying disease at entry
to determine if platelet reactivity assessed by specific and non-specific tests is predictive of bleeding events during the 3-year follow-up
to investigate potential determinants of platelet reactivity at entry in the study
Main objective
to determine if platelet reactivity assessed by specific and non-specific tests is predictive of ischemic events during the 3-year follow-up
Secondary objectives
primary outcome in each pre-specified sub-group patients with coronary artery disease ischemic stroke or peripheral arterial disease as main qualifying disease at entry
to determine if platelet reactivity assessed by specific and non-specific tests is predictive of bleeding events during the 3-year follow-up
to investigate potential determinants of platelet reactivity at entry in the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CPP SUDMED IV 051201 | None | None | None |